Literature DB >> 35511722

CORP: Gene delivery into murine skeletal muscle using in vivo electroporation.

David C Hughes1, Justin P Hardee2, David S Waddell3, Craig A Goodman2.   

Abstract

The strategy of gene delivery into skeletal muscles has provided exciting avenues in identifying new potential therapeutics toward muscular disorders and addressing basic research questions in muscle physiology through overexpression and knockdown studies. In vivo electroporation methodology offers a simple, rapidly effective technique for the delivery of plasmid DNA into postmitotic skeletal muscle fibers and the ability to easily explore the molecular mechanisms of skeletal muscle plasticity. The purpose of this review is to describe how to robustly electroporate plasmid DNA into different hindlimb muscles of rodent models. Furthermore, key parameters (e.g., voltage, hyaluronidase, and plasmid concentration) that contribute to the successful introduction of plasmid DNA into skeletal muscle fibers will be discussed. In addition, details on processing tissue for immunohistochemistry and fiber cross-sectional area (CSA) analysis will be outlined. The overall goal of this review is to provide the basic and necessary information needed for successful implementation of in vivo electroporation of plasmid DNA and thus open new avenues of discovery research in skeletal muscle physiology.

Entities:  

Keywords:  atrophy; electroporation; gene transfer; hypertrophy; protein synthesis

Mesh:

Substances:

Year:  2022        PMID: 35511722      PMCID: PMC9236869          DOI: 10.1152/japplphysiol.00088.2022

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  190 in total

Review 1.  Fluorescent proteins as biomarkers and biosensors: throwing color lights on molecular and cellular processes.

Authors:  Olesya V Stepanenko; Vladislav V Verkhusha; Irina M Kuznetsova; Vladimir N Uversky; K K Turoverov
Journal:  Curr Protein Pept Sci       Date:  2008-08       Impact factor: 3.272

2.  Physiological effects of high- and low-voltage pulse combinations for gene electrotransfer in muscle.

Authors:  Pernille Hojman; Hanne Gissel; Franck M Andre; Christelle Cournil-Henrionnet; Jens Eriksen; Julie Gehl; Lluis M Mir
Journal:  Hum Gene Ther       Date:  2008-11       Impact factor: 5.695

Review 3.  Adaptations to Endurance and Strength Training.

Authors:  David C Hughes; Stian Ellefsen; Keith Baar
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

4.  The electrical characteristics of fixed charge membranes: solution of the field equations.

Authors:  H G Coster; E P George; R Simons
Journal:  Biophys J       Date:  1969-05       Impact factor: 4.033

5.  Functional EGFP-dystrophin fusion proteins for gene therapy vector development.

Authors:  P Chapdelaine; P A Moisset; P Campeau; I Asselin; J T Vilquin; J P Tremblay
Journal:  Protein Eng       Date:  2000-09

Review 6.  Skeletal Muscle Atrophy: Discovery of Mechanisms and Potential Therapies.

Authors:  Scott M Ebert; Asma Al-Zougbi; Sue C Bodine; Christopher M Adams
Journal:  Physiology (Bethesda)       Date:  2019-07-01

Review 7.  Factors modulating expression of Renilla luciferase from control plasmids used in luciferase reporter gene assays.

Authors:  Amde Selassie Shifera; John A Hardin
Journal:  Anal Biochem       Date:  2009-09-27       Impact factor: 3.365

8.  Coexpression after electroporation of plasmid mixtures into muscle in vivo.

Authors:  Z A Rana; M Ekmark; K Gundersen
Journal:  Acta Physiol Scand       Date:  2004-06

9.  Insights into the role and regulation of TCTP in skeletal muscle.

Authors:  Craig A Goodman; Allison M Coenen; John W Frey; Jae-Sung You; Robert G Barker; Barnaby P Frankish; Robyn M Murphy; Troy A Hornberger
Journal:  Oncotarget       Date:  2017-03-21

10.  Optimization of ectopic gene expression in skeletal muscle through DNA transfer by electroporation.

Authors:  Jordan Taylor; Charlie F Babbs; Mohammed Borhan Alzghoul; Aaron Olsen; Mickey Latour; Amber L Pond; Kevin Hannon
Journal:  BMC Biotechnol       Date:  2004-05-18       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.